These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 5673364)
1. Isolation of chlorpromazine pigments in man. Van Woert MH Nature; 1968 Sep; 219(5158):1054-6. PubMed ID: 5673364 [No Abstract] [Full Text] [Related]
2. [Comparative studies on lipofuscin of various origin from human and animal liver]. Berneis K; Studer A Pathol Microbiol (Basel); 1968; 31(2):108-16. PubMed ID: 5650637 [No Abstract] [Full Text] [Related]
3. Resolution of chlorpromazine-induced pigmentation with haloperidol substitution. Thompson TR; Lal S; Yassa R; Gerstein W Acta Psychiatr Scand; 1988 Dec; 78(6):763-5. PubMed ID: 3223334 [TBL] [Abstract][Full Text] [Related]
4. Chlorpromazine-induced cutaneous pigmentation--effect of replacement with clozapine. Lal S; Lal S J Psychiatry Neurosci; 2000 May; 25(3):281. PubMed ID: 10863889 [No Abstract] [Full Text] [Related]
5. Chlorpromazine-induced skin pigmentation with corneal and lens opacities. Huff LS; Prado R; Pederson JF; Dunnick CA; Lucas LM Cutis; 2014 May; 93(5):247-50. PubMed ID: 24897137 [TBL] [Abstract][Full Text] [Related]
6. Resolution of chlorpromazine-induced cutaneous pigmentation following substitution with levomepromazine or other neuroleptics. Bloom D; Krishnan B; Thavundayil JX; Lal S Acta Psychiatr Scand; 1993 Mar; 87(3):223-4. PubMed ID: 8096668 [TBL] [Abstract][Full Text] [Related]
7. Therapy of Phenothiazine-produced skin pigmentation: a preliminary report. Gibbard BA; Lehmann HE Am J Psychiatry; 1966 Sep; 123(3):351-2. PubMed ID: 5917622 [No Abstract] [Full Text] [Related]
9. Negligible hepatotoxicity of chlorpromazine in long-term therapy. Weinreb M; Kraus V; Krausová J; Hudcová T Act Nerv Super (Praha); 1978 Dec; 20(4):280-1. PubMed ID: 735735 [No Abstract] [Full Text] [Related]
10. [Effect of long-term therapy with aminazin on the structure and function of the liver]. Avrutskiĭ GIa; Gurovich IIa; Romanov IuD; Khmelevskiĭ DL; Mukhin AS Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(7):1050-5. PubMed ID: 5077762 [No Abstract] [Full Text] [Related]
11. Blue skin pigmentation and chlorpromazine. Haddad RI J Ky Med Assoc; 1977 Mar; 75(3):124-6. PubMed ID: 839129 [No Abstract] [Full Text] [Related]
13. Neuroleptic-induced skin pigmentation in chronic hospitalized schizophrenic patients. Ban TA; Guy W; Wilson WH Can J Psychiatry; 1985 Oct; 30(6):406-8. PubMed ID: 2866025 [TBL] [Abstract][Full Text] [Related]
14. Treatment of chronic schizophrenia with tri-iodothyronine. Simpson GM; Amuso D Can Psychiatr Assoc J; 1966 Aug; 11(4):303-5. PubMed ID: 5967398 [No Abstract] [Full Text] [Related]
15. [Abnormally high tissue levels of brown pigment under amiodarone administration]. Barchewitz G; Laurent G; Jamaer M Arch Int Pharmacodyn Ther; 1970 Mar; 184(1):59-67. PubMed ID: 4194559 [No Abstract] [Full Text] [Related]
16. An electron microscopic study of chlorpromazine pigmentation. Hashimoto K; Wiener W; Albert J; Nelson RG J Invest Dermatol; 1966 Oct; 47(4):296-306. PubMed ID: 5954160 [No Abstract] [Full Text] [Related]
17. Ocular changes produced by chlorpromazine. Dencker SJ; Enoksson P Acta Ophthalmol (Copenh); 1966; 44(3):397-403. PubMed ID: 5953234 [No Abstract] [Full Text] [Related]
18. Rabbit as a model for chlorpromazine-induced hyperpigmentation of the skin. Forrest IS; Kosek JC; Aber RC; Serra MT Biochem Pharmacol; 1970 Mar; 19(3):849-52. PubMed ID: 5507689 [No Abstract] [Full Text] [Related]
19. Relation of graded ocular anterior chamber pigmentation to phenothiazine intake in schizophrenics--quantification procedures. Thaler JS; Curinga R; Kiracofe G Am J Optom Physiol Opt; 1985 Sep; 62(9):600-4. PubMed ID: 4050962 [TBL] [Abstract][Full Text] [Related]
20. An animal model for chlorpromazine-induced hyperpigmentation of the skin. Forrest IS; Aber RC; Kosek JC; Serra MT Proc West Pharmacol Soc; 1969; 12():36-40. PubMed ID: 5812296 [No Abstract] [Full Text] [Related] [Next] [New Search]